Johns Hopkins ABX Guide
Cefixime
INDICATIONS
FDA
FDA
- Otitis media caused by H. influenzae, M. catarrhalis and S. pyogenes
- Pharyngitis and tonsillitis caused by S. pyogenes (PCN is the drug of choice)
- Acute bronchitis and acute exacerbation of chronic bronchitis (AECB) caused by S. pneumoniae and H. influenzae (note: relatively poor S. pneumoniae activity)
- Uncomplicated urinary tract infections caused by E. coli and P. mirabilis
- Uncomplicated gonorrhea (cervicitis and urethritis, see NOTE under COMMENTS regarding use of cefixime for treating gonorrhea)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Sinusitis, acute (not a first line agent)
- Prophylaxis after sexual victimization
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 2, 2018
Citation
Avdic, Edina, and Paul A Pham. "Cefixime." Johns Hopkins ABX Guide, The Johns Hopkins University, 2018. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540091/all/Cefixime.
Avdic E, Pham PA. Cefixime. Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540091/all/Cefixime. Accessed July 24, 2025.
Avdic, E., & Pham, P. A. (2018). Cefixime. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540091/all/Cefixime
Avdic E, Pham PA. Cefixime [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. [cited 2025 July 24]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540091/all/Cefixime.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cefixime
ID - 540091
A1 - Avdic,Edina,Pharm.D.
AU - Pham,Paul,Pharm.D. BCPS
Y1 - 2018/10/02/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540091/all/Cefixime
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
